Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 684.54%.

  • Firefly Neuroscience's EBIT Margin rose 122488000.0% to 684.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 1450.52%, marking a year-over-year increase of 96102900.0%. This contributed to the annual value of 618.07% for FY2023, which is 5689100.0% down from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's EBIT Margin is 684.54%, which was up 122488000.0% from 546.49% recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's EBIT Margin ranged from a high of 6247.27% in Q4 2024 and a low of 12933.33% during Q3 2024
  • For the 5-year period, Firefly Neuroscience's EBIT Margin averaged around 2409.7%, with its median value being 55.99% (2022).
  • Over the last 5 years, Firefly Neuroscience's EBIT Margin had its largest YoY gain of 144946400bps in 2024, and its largest YoY loss of -126143600bps in 2024.
  • Firefly Neuroscience's EBIT Margin (Quarter) stood at 110.99% in 2021, then soared by 54bps to 51.38% in 2022, then crashed by -15951bps to 8247.37% in 2023, then surged by 176bps to 6247.27% in 2024, then crashed by -111bps to 684.54% in 2025.
  • Its EBIT Margin was 684.54% in Q3 2025, compared to 546.49% in Q2 2025 and 4802.33% in Q1 2025.